GENERAL INFORMATION
PATRONAGE
CONGRESS VENUE
Porto Antico di Genova Centro Congressi
16128 Genova • Italy
Tel. (+39) 010 2485611
Fax (+39) 010 2758929
Università degli Studi di Genova
ERA - EDTA
Associazione Medici Diabetologi
Società Italiana di Diabetologia
Società Italiana dell’Ipertensione Arteriosa
Società Italiana di Medicina Interna
Società Italiana di Nefrocardiologia
Società Italiana di Nefrologia
HOW TO REACH GENOA
• By plane: "Cristoforo Colombo" Airport, Genoa
• By train: "Genova Principe" railway station
• By car: Highways A7, A10 (exit Genova Ovest and then
follow the indications to Porto Antico)
REGISTRATION FEE
150,00 Euro (VAT included) for under 30 and postgraduated students
360,00 Euro (VAT included) for others
The registration fee includes:
• Admission to all the scientific sessions
• CME accreditation
• Congress kit
CME
The Meeting has been submitted for approval for continuing
education units to the Italian Health Ministry.
OFFICIAL LANGUAGES
The official language of the Congress is English.
WEB SITE
The congress page is available on the web at the following
address: www.genoameeting.org
PRESIDENT
G. Deferrari
Clinica di Nefrologia
Di.M.I.
IRCCS Azienda Ospedaliera Universitaria
San Martino - IST Istituto Nazionale per la Ricerca sul Cancro
SCIENTIFIC COMMITTEE
G. Deferrari, C. Borghi, D. De Zeeuw, P. Fioretto,
F. Locatelli, R. Pontremoli, A. Salvetti, M. Volpe, C. Zoccolai
GENOA MEETING
ON
HYPERTENSION,
DIABETES
AND
RENAL DISEASES
SCIENTIFIC SECRETARIAT
Clinica di Nefrologia
Di.M.I.
IRCCS Azienda Ospedaliera Universitaria
San Martino - IST Istituto Nazionale per la Ricerca sul Cancro
Largo Rosanna Benzi, 10 • 16132 Genova • Italy
Tel. (+39) 010 3537972 • Fax (+39) 010 5535970
E-mail genoameeting@aristea.com
ORGANIZING SECRETARIAT
Via Roma, 10 • 16121 Genova • Italy
Tel. (+39) 010 553591 • Fax (+39) 010 5535970
E-mail genova@aristea.com • Web www.aristea.com
PRELIMINARY PROGRAMME
PORTO ANTICO DI GENOVA
CENTRO CONGRESSI, ITALY
FEBRUARY 20 -22, 2014
P r
P ROGRAM
S CIENTIFIC C OMMITTEE
o g r a m
Thursday, February 20, 2014
Giacomo Deferrari
14.30
Opening Remarks
15.00
ROUND TABLE
Chairman: TBD
THE UNIVERSITY HOSPITAL
14.00
SATELLITE SYMPOSIUM
15.00
LECTURE SESSION
Chairmen: TBD
• Salt under the skin: Hypertension,
cardiovascular disease and on osmotic
sodium accumulation - J.M. Titze
• The heart as a biomarker of global
cardiovascular risk in CKD - E. Paoletti
16.00
Coffee Break
16.30
SATELLITE SYMPOSIUM
Paola Fioretto
Francesco Locatelli
Massimo Volpe
Roberto Pontremoli
TODAY AND TOMORROW:
AT THE CROSSROAD BETWEEN ACADEMIC MISSION
Claudio Borghi
AND THE
Antonio Salvetti
16.30
Carmine Zoccali
FACULTY
C. Borghi
Bologna
F. Locatelli
Lecco
G. Mancia
Milano
E. Paoletti
Genova
J. Redon
Valencia (Spain)
G. Schillaci
Perugia
A. Stella
Milano
J.M. Titze
Erlangen (Germany)
A. Zanchetti
Milano
NHS
NEEDS
LECTURE SESSION
Chairman: TBD
• New and less Erythropoietin Stimulating
Agents: an update - F. Locatelli
• The EVOLVE trial: shades, lights
and where to go - TBD
18.00
LECTURE SESSION
Chairman: TBD
19.00
Welcome Cocktail
P ROGRAM
P r o g r a m
Friday, February 21, 2014
08.30
ROUND TABLE
Chairmen: TBD
NEW ESH-ESC GUIDELINES
• What’s new - G. Mancia
• What has been confirmed - J. Redon
10.30
Coffee Break
11.00
LECTURE SESSION
BP Monitoring and vascular stiffness
Chairmen: TBD
• Usefulness of BP variability
in the clinical setting - TBD
• How to measure vascular stiffness,
and why should we care - G. Schillaci
12.00
SATELLITE SYMPOSIUM
Supported by Menarini
13.00
Working Lunch served in the foyer
P r
P ROGRAM
o g r a m
Saturday, February 22, 2014
09.00
LECTURE SESSION
Resistant Hypertension:
Medical Treatment Vs Intervention
Chairmen: TBD
• Sequential nephron block - TBD
• Renal Denervation - A. Stella
10.00
LECTURE
The problem of CV prevention:
the “earlier” or the “lower”
is better? - C. Borghi
10.30
Coffee Break
11.00
LECTURE SESSION
Chairmen: TBD
• Optimizing treatment strategies
in hypertension: should a diuretic
or calcium channel blockers be
preferred in combination with
an RAAS-Inhibitor? - TBD
• Changes in subclinical organ damage:
are they really useful in the
management of hypertensive
patients? - A. Zanchetti
12.30
Closing remarks